Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antiphospholipid Syndrome
Researchers review antiphospholipid syndrome
June 13th, 2005
Researchers in Israel take a look at antiphospholipid syndrome. "The anticardiolipin (aCL) antibody test was first established in 1983, using cardiolipin (negatively charged phospholipid) as an antigen in a solid-phase immunoassy. It was first applied to the study of systemic lupus erythematosus patients, and was found associated with thromboses and recurrent pregnancy losses," reported I. Marai and associates at Tel Aviv University. "The wide use of this test was determinant in the definition of the aCL or antiphospholipid syndrome (APS). Later, it was demonstrated that aCL antibodies do not recognize anionic phospholipids but are directed against...
Source: Health & Medicine Week (2005-06-13)
|
